Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BeOne Medicines Ltd. | Director | Ordinary Shares | 27.3K | $6.37M | $233.25 | Jun 10, 2025 | Direct |
BeiGene, Ltd. | Director | Share Option (Right to Buy) | 22.8K | May 21, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONC | BeOne Medicines Ltd. | Jun 10, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
BGNE | BeiGene, Ltd. | May 21, 2025 | 2 | $0 | 4 | May 23, 2025 | Director |
BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
BGNE | BeiGene, Ltd. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
BGNE | BeiGene, Ltd. | Aug 22, 2022 | 1 | $0 | 4 | Aug 24, 2022 | Director |
BGNE | BeiGene, Ltd. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
BGNE | BeiGene, Ltd. | Jun 16, 2021 | 2 | $0 | 4 | Jun 24, 2021 | Director |